{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:04Z","timestamp":1792291144834,"version":"4.4.0"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006772","name":"Max and Minnie Tomerlin Voelcker Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003712","name":"Korea Food Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"DOI":"10.3389\/fmolb.2020.588913","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T06:12:08Z","timestamp":1602828728000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens"],"prefix":"10.3389","volume":"7","author":[{"given":"Sandeep","family":"Vellanki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/pmic.201400584","article-title":"Comparative proteomics of a TOR inducible Aspergillus fumigatus mutant reveals involvement of the Tor kinase in iron regulation.","volume":"15","author":"Baldin","year":"2015","journal-title":"Proteomics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10295-015-1677-7","article-title":"The biosynthetic pathway of FK506 and its engineering: from past achievements to future prospects.","volume":"43","author":"Ban","year":"2016","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/np4001224","article-title":"Characterization of FK506 biosynthetic intermediates involved in post-PKS elaboration.","volume":"76","author":"Ban","year":"2013","journal-title":"J. Nat. Prod."},{"key":"B4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1128\/ec.05284-11","article-title":"Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of TOR.","volume":"11","author":"Bastidas","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12281-019-00350-w","article-title":"Small-molecule protein kinases inhibitors and the risk of fungal infections.","volume":"13","author":"Bechman","year":"2019","journal-title":"Curr. Fungal Infect. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1021\/acs.jnatprod.9b00144","article-title":"Biosynthesis of nonimmunosuppressive FK506 analogues with antifungal activity.","volume":"82","author":"Beom","year":"2019","journal-title":"J. Nat. Prod."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1128\/iai.73.9.5767-5774.2005","article-title":"Calcineurin is required for Candida albicans to survive calcium stress in serum.","volume":"73","author":"Blankenship","year":"2005","journal-title":"Infect. Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/ec.2.3.422-430.2003","article-title":"Calcineurin is essential for Candida albicans survival in serum and virulence.","volume":"2","author":"Blankenship","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.mib.2010.04.009","article-title":"Interaction of phagocytes with filamentous fungi.","volume":"13","author":"Brakhage","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0035-3787(06)75005-6","article-title":"Cryptococcal meningo-encephalitis in an apparently immunocompetent patient.","volume":"162","author":"Bretaudeau","year":"2006","journal-title":"Rev. Neurol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16123-9","article-title":"Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14\u03b1-demethylase.","volume":"7","author":"Caramalho","year":"2017","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1101\/gad.13.24.3271","article-title":"The TOR signaling cascade regulates gene expression in response to nutrients.","volume":"13","author":"Cardenas","year":"1999","journal-title":"Genes Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/13693786.2012.715763","article-title":"Fluconazole resistance in cryptococcal disease: emerging or intrinsic?","volume":"51","author":"Cheong","year":"2013","journal-title":"Med. Mycol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2019.02.008","article-title":"The fungal cell wall as a target for the development of new antifungal therapies.","volume":"37","author":"Cort\u00e9s","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1128\/ec.00086-08","article-title":"Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatus.","volume":"7","author":"Cramer","year":"2008","journal-title":"Eukaryot. Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1128\/mcb.19.6.4101","article-title":"Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.","volume":"19","author":"Cruz","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3162-3170.2001","article-title":"Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-Dependent Inhibition of Tor.","volume":"45","author":"Cruz","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.205","article-title":"Antifungal drugs: small molecules targeting a tertiary RNA structure fight fungi.","volume":"17","author":"Cully","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ijantimicag.2017.08.010","article-title":"Antifungal resistance in mucorales.","volume":"50","author":"Dannaoui","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002870","article-title":"Major role for amphotericin B-flucytosine combination in severe cryptococcosis.","volume":"3","author":"Dromer","year":"2008","journal-title":"PLoS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.176.3.751","article-title":"The immunosuppressive and toxic effects of FK506 are mechanistically related: pharmacology of a novel antagonist of FK506 and rapamycin.","volume":"176","author":"Dumont","year":"1992","journal-title":"J. Exp. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","article-title":"Invasive fungal infections: a review of epidemiology and management options.","volume":"55","author":"Enoch","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137869","article-title":"Characterization of the FKBP12-encoding genes in Aspergillus fumigatus.","volume":"10","author":"Falloon","year":"2015","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1128\/aac.00854-09","article-title":"Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofungin.","volume":"54","author":"Fortwendel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1097\/00002030-200111230-00026","article-title":"Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.","volume":"15","author":"Friese","year":"2001","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02921-15","article-title":"In vitro interactions between target of rapamycin kinase inhibitor and antifungal agents against Aspergillus Species.","volume":"60","author":"Gao","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29973-8","article-title":"A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion.","volume":"8","author":"Garcia","year":"2018","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.14.039800","article-title":"Designing selective and non-immunosuppressive antifungal FK506 analogs: structures, biophysics and dynamics of fungal and human calcineurin-inhibitor complexes.","author":"Gobeil","year":"2020","journal-title":"bioRxiv[Preprint]."},{"key":"B29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12104-019-09878-x","article-title":"(15)N, (13)C and (1)H resonance assignments of FKBP12 proteins from the pathogenic fungi Mucor circinelloides and Aspergillus fumigatus.","volume":"13","author":"Gobeil","year":"2019","journal-title":"Biomol. NMR Assign."},{"key":"B30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41557-018-0187-4","article-title":"Rapamycin-inspired macrocycles with new target specificity.","volume":"11","author":"Guo","year":"2019","journal-title":"Nat. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.1128\/mcb.13.8.5010","article-title":"The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae.","volume":"13","author":"Heitman","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/infdis\/175.1.222","article-title":"Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin).","volume":"175","author":"High","year":"1997","journal-title":"J. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1086\/375822","article-title":"Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.","volume":"37","author":"Husain","year":"2003","journal-title":"Clin. Infect. Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/17460441.2017.1349751","article-title":"Approaches for discovering novel bioactive small molecules targeting autophagy.","volume":"12","author":"Hwang","year":"2017","journal-title":"Exp. Opin. Drug Discov."},{"key":"B37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrmicro1245","article-title":"Deciphering the Model Pathogenic Fungus Cryptococcus Neoformans.","volume":"3","author":"Idnurm","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbrc.2020.03.062","article-title":"FKBP12 dimerization mutations effect FK506 binding and differentially alter calcineurin inhibition in the human pathogen Aspergillus fumigatus.","volume":"526","author":"Juvvadi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12199-1","article-title":"Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents.","volume":"10","author":"Juvvadi","year":"2019","journal-title":"Nat. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.fbr.2014.02.004","article-title":"Calcineurin as a multifunctional regulator: unraveling novel functions in fungal stress responses, hyphal growth, drug resistance, and pathogenesis.","volume":"28","author":"Juvvadi","year":"2014","journal-title":"Fungal Biol. Rev."},{"key":"B41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1074\/jbc.M117.807032","article-title":"Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6\/ROA1 depends on TOR signaling.","volume":"293","author":"Khandelwal","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1249","article-title":"FK506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot"},{"key":"B43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jac\/dkg090","article-title":"Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.","volume":"51","author":"Kontoyiannis","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"20457","DOI":"10.1074\/jbc.C300133200","article-title":"Rapamycin-induced translational derepression of GCN4 mRNA involves a novel mechanism for activation of the eIF2 alpha kinase GCN2.","volume":"278","author":"Kubota","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity.","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003625","article-title":"calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides.","volume":"9","author":"Lee","year":"2013","journal-title":"PLoS Pathog"},{"key":"B48","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/mmi.13071","article-title":"Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host\u2013pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.","volume":"97","author":"Lee","year":"2015","journal-title":"Mol. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1627","DOI":"10.1128\/aac.01627-18","article-title":"In vitro and in vivo assessment of FK506 analogs as novel antifungal drug candidates.","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02573","article-title":"Fungal cell wall: emerging antifungals and drug resistance.","volume":"10","author":"Lima","year":"2019","journal-title":"Front. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-h","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.111.133363","article-title":"Target of Rapamycin (TOR) in nutrient signaling and growth control.","volume":"189","author":"Loewith","year":"2011","journal-title":"Genetics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/21505594.2018.1435249","article-title":"Understanding Mucor circinelloides pathogenesis by comparative genomics and phenotypical studies.","volume":"9","author":"L\u00f3pez-Fern\u00e1ndez","year":"2018","journal-title":"Virulence"},{"key":"B54","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.","volume":"20","author":"Lortholary","year":"2006","journal-title":"AIDS"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3410\/m3-14","article-title":"Emerging fungal infections in immunocompromised patients.","volume":"3","author":"Low","year":"2011","journal-title":"F"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1128\/aac.44.9.2296-2303.2000","article-title":"Transcriptional analyses of antifungal drug resistance in Candida albicans.","volume":"44","author":"Lyons","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","article-title":"History of the development of azole derivatives.","volume":"10","author":"Maertens","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1139\/y77-007","article-title":"Inhibition of the immune response by rapamycin, a new antifungal antibiotic.","volume":"55","author":"Martel","year":"1977","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.4.2012-2019.2005","article-title":"Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.","volume":"73","author":"Mednick","year":"2005","journal-title":"Infect. Immun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am. J. Transplant."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5930489","article-title":"High virulence and antifungal resistance in clinical strains of Candida albicans.","volume":"2016","author":"Monroy-P\u00e9rez","year":"2016","journal-title":"Can J Infect Dis Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.bmcl.2017.04.004","article-title":"A calcineurin antifungal strategy with analogs of FK506.","volume":"27","author":"Nambu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/femsyr\/fov081","article-title":"Candida albicans commensalism in the gastrointestinal tract.","volume":"15","author":"Neville","year":"2015","journal-title":"FEMS Yeast Res."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224776","article-title":"Target Of Rapamycin pathway in the white-rot fungus Phanerochaete chrysosporium.","volume":"15","author":"Nguyen","year":"2020","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.41.1.156","article-title":"The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein.","volume":"41","author":"Odom","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/emboj\/16.10.2576","article-title":"Calcineurin is required for virulence of Cryptococcus neoformans.","volume":"16","author":"Odom","year":"","journal-title":"EMBO J."},{"key":"B68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.idc.2010.01.002","article-title":"Fungal infections in transplant and oncology patients.","volume":"24","author":"Person","year":"2010","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis.","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1128\/jcm.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.","volume":"42","author":"Pfaller","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem.","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.coph.2013.08.008","article-title":"Antifungal therapy with an emphasis on biofilms.","volume":"13","author":"Pierce","year":"2013","journal-title":"Curr. Opin. Pharmacol"},{"key":"B73","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1016\/S0021-9258(18)52995-1","article-title":"Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis.","volume":"268","author":"Rotonda","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1152\/physrev.2000.80.4.1483","article-title":"Calcineurin: form and function.","volume":"80","author":"Rusnak","year":"2000","journal-title":"Physiol. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease.","volume":"30","author":"Saag","year":"2000","journal-title":"Clin. Infect. Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","article-title":"Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence.","volume":"48","author":"Sanglard","year":"2003","journal-title":"Mol. Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: A review of the evidence.","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506.","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol. Today"},{"key":"B79","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7164\/antibiotics.28.727","article-title":"Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.","volume":"28","author":"Sehgal","year":"1975","journal-title":"J. Antibiot."},{"key":"B80","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nchembio.2165","article-title":"Dual action antifungal small molecule modulates multidrug efflux and TOR signaling.","volume":"12","author":"Shekhar-Guturja","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1039\/C4RA11907J","article-title":"A non-immunosuppressive FK506 analogue with neuroregenerative activity produced from a genetically engineered Streptomyces strain.","volume":"5","author":"Shinde","year":"2015","journal-title":"RSC Adv."},{"key":"B82","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1128\/aac.01299-15","article-title":"Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda.","volume":"59","author":"Smith","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1534\/genetics.119.302191","article-title":"The TOR Pathway plays pleiotropic roles in growth and stress responses of the fungal pathogen Cryptococcus neoformans.","volume":"212","author":"So","year":"2019","journal-title":"Genetics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1128\/ec.00139-06","article-title":"Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus.","volume":"5","author":"Steinbach","year":"2006","journal-title":"Eukaryot. Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nrmicro1680","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.","volume":"5","author":"Steinbach","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1128\/aac.48.5.1664-1669.2004","article-title":"In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.","volume":"48","author":"Steinbach","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/jobm.3620300522","article-title":"F. C. Odds, Candida and Candidosis, A Review and Bibliography (Second Edition). X + 468 S., 97 Abb., 92 Tab. u. 22 Farbtafeln. London\u2014Philadelphia\u2014Toronto\u2014Sydney\u2014Tokyo 1988. Bailli\u00e8re Tindall (W. B. Saunders). \u00a3 35.00. ISBN: 0\u20137020\u20131265\u20133.","volume":"30","author":"Stelzner","year":"1990","journal-title":"J. Basic Microbiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/0167-5699(89)90057-1","article-title":"FK506\u2013how much potential?","volume":"10","author":"Thomson","year":"1989","journal-title":"Immunol. Today"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00492-16","article-title":"Structures of pathogenic fungal FKBP12s reveal possible self-catalysis function.","volume":"7","author":"Tonthat","year":"2016","journal-title":"mBio"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e002949","DOI":"10.1128\/mBio.02949-19","article-title":"A novel resistance pathway for calcineurin inhibitors in the human-pathogenic mucorales mucor circinelloides.","volume":"11","author":"Vellanki","year":"2020","journal-title":"mBio"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.53","article-title":"Mucor circinelloides: growth, Maintenance, and Genetic Manipulation.","volume":"49","author":"Vellanki","year":"2018","journal-title":"Curr. Protoc. Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/21505594.2016.1197444","article-title":"Targeting Candida albicans filamentation for antifungal drug development.","volume":"8","author":"Vila","year":"2017","journal-title":"Virulence"},{"key":"B93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ccm.2017.04.008","article-title":"Approach to fungal infections in human immunodeficiency virus-infected individuals: pneumocystis and beyond.","volume":"38","author":"Wang","year":"2017","journal-title":"Clin. Chest. Med."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida Species.","volume":"7","author":"Whaley","year":"2016","journal-title":"Front. Microbiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/idr.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat.","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"B97","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3201\/eid2604.190840","article-title":"Multicenter Study of Azole-Resistant Aspergillus fumigatus Clinical Isolates, Taiwan(1).","volume":"26","author":"Wu","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1016\/j.bmc.2017.06.002","article-title":"Discovery of simplified leucyladenylate sulfamates as novel leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.","volume":"25","author":"Yoon","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12281-019-00343-9","article-title":"Fungal infections with ibrutinib and other small-molecule kinase inhibitors.","volume":"13","author":"Zarakas","year":"2019","journal-title":"Curr. Fungal Infect. Rep."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmolb.2020.588913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T01:49:33Z","timestamp":1617932973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmolb.2020.588913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":99,"alternative-id":["10.3389\/fmolb.2020.588913"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2020.588913","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"article-number":"588913"}}